Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.3B | 10.4B | 10.1B | 9.7B |
Cost of revenue | 5.0B | 4.8B | 4.6B | 4.5B |
Gross profit | 5.3B | 5.6B | 5.5B | 5.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.4B | 2.6B | 2.4B | 2.5B |
Other operating expenses | — | 145.3M | 132.3M | 339.1M |
Operating income | 5.3B | 187.3M | 283.0M | -431.2M |
Non operating interest income | ||||
Income | — | 479.4M | 477.5M | 473.4M |
Expense | — | 27.0M | 29.5M | 30.2M |
Other income expense | — | — | — | — |
Pretax income | 2.0B | 6.3B | 2.5B | 1.1B |
Tax provision | 420.2M | 829.6M | 375.3M | 59.5M |
Net income | 1.6B | 5.5B | 2.1B | 1.0B |
Basic EPS | 161.8 | — | 214 | 103 |
Diluted EPS | 161.8 | — | 214 | 103 |
Basic average shares | — | — | 10.0M | 10.0M |
Diluted average shares | — | — | 10.0M | 10.0M |
EBITDA | 5.3B | 6.6B | 2.9B | 1.4B |
Net income from continuing op. | — | 5.5B | 2.1B | 1.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |